2025-08-03 - Analysis Report
Okay, here's a comprehensive analysis of UnitedHealth Group Inc (UNH) based on the provided data.  The report is structured to provide a clear overview, incorporating the requested numerical highlights and analytical insights.

## UnitedHealth Group Inc (UNH) Stock Analysis

**0. Executive Summary**

This report analyzes the recent performance and outlook for UnitedHealth Group Inc (UNH), a leading health insurance and healthcare services company.  The analysis considers relative performance against the S&P 500 (VOO), technical indicators, recent news, earnings, and financial data to provide a comprehensive assessment.

**1. Relative Performance Analysis**

*   **Ticker:** UNH
*   **Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing health benefits and services.
*   **UNH Cumulative Return:** -21.59%
*   **S&P 500 (VOO) Cumulative Return:** 94.15%
*   **Divergence:**
    *   Max: 28.9
    *   Min: -101.1
    *   Current: -101.1
    *   Relative Divergence: 0.0

**Analysis:** The significant negative divergence indicates substantial underperformance of UNH relative to the S&P 500. The relative divergence of 0.0 suggests that UNH is currently at the lowest end of its historical divergence range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha    | Beta   | Cap(B)  |
| :----------- | :------ | :------ | :------- | :----- | :------ |
| 2015-2017  | -1.0%   | 1.0%    | -30.0%   | -14.9 | 200.0   |
| 2016-2018  | 0.0%    | 63.4%   | -18.0%   | -0.9  | 226.0   |
| 2017-2019  | 21.0%   | 63.4%   | -9.0%    | -0.8  | 266.7   |
| 2018-2020  | 7.0%    | 63.4%   | -13.0%   | -0.1  | 318.1   |
| 2019-2021  | 43.0%   | 60.6%   | -6.0%    | 0.2   | 455.5   |
| 2020-2022  | 32.0%   | 66.6%   | 30.0%    | 0.3   | 480.9   |
| 2021-2023  | 33.0%   | 67.5%   | 15.0%    | 0.7   | 477.6   |
| 2022-2024  | -19.0%  | 68.7%   | -44.0%   | 0.4   | 458.9   |
| 2023-2025  | -62.0%  | 75.5%   | -108.0%  | 0.1   | 215.7   |

**Analysis:**

*   **CAGR:** The recent negative CAGR values (-19.0%, -62.0%) highlight significant recent underperformance.
*   **MDD:** Consistently high Maximum Drawdown (MDD) values indicate substantial risk and volatility.
*   **Alpha:**  Negative Alpha values, especially the recent -44.0% and -108.0%, confirm the underperformance relative to the benchmark (S&P 500). Positive Alpha in 2020-2022 is an outlier.
*   **Beta:** Beta values generally indicate lower volatility than the market, except for 2015-2017.
*   **Cap(B):** Market capitalization declined sharply to 215.7B after consecutive quarters of steady performance.

**2. Recent Price Action**

*   **Current Price:** $237.77
*   **Last Market Data:**
    *   Price: $237.77
    *   Previous Close: $249.56
    *   Change: -4.72
*   **Moving Averages:**
    *   5-day MA: $259.31
    *   20-day MA: $284.21
    *   60-day MA: $303.11

**Analysis:** The price is significantly below all three moving averages, indicating a strong downtrend.  The negative change from the previous close (-$4.72) reinforces the downward momentum.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3358 (Low Risk)
*   **RSI:** 19.25 (Oversold)
*   **PPO:** -1.48
*   **Hybrid Signal:** "cash_0%_Buy 80% of cash (3 shares - Caution - MRI:0.33) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-07-01)"
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Negative Trend)
*   **Expected Return:** -869.2%

**Analysis:**

*   **MRI:** While the MRI indicates low market risk, this may be misleading given the stock's specific underperformance.
*   **RSI:** The RSI value of 19.25 suggests the stock is heavily oversold, which *could* indicate a potential for a short-term bounce.  However, in a strong downtrend, oversold conditions can persist.
*   **PPO:** The negative PPO value confirms the downward trend in price momentum.
*   **Hybrid Signal:** The Hybrid Signal suggests a cautious approach, recommending buying 80% of cash with a small monthly investment, reflecting uncertainty.
*   **Relative Divergence Change:** The unchanged relative divergence change indicates the bearishness continues.
*   **Significant Price Change:** The price change of -4.72 indicates a significant downward momentum.
*   **Expected Return:** The highly negative expected return indicates significant concerns about future performance relative to the S&P 500, even with long-term dollar-cost averaging. This suggests that, based on current trends, UNH is projected to substantially underperform the S&P 500 over the long term.

**4. Recent News & Significant Events**

*   **[2025-07-31]:** Major business developments, regulatory changes, or market events impacting UNH.
*   **[2025-08-03]:** Analyst discussions on UNH's recent performance and outlook.
*   **[2025-08-02]:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-08-01]:** Market experts highlighting both risks and opportunities for UNH.

**Analysis:** The news items indicate ongoing volatility and scrutiny of UNH, driven by various factors. Investors should closely monitor company announcements and further news.

**5. Recent Earnings Analysis**

| Date       | EPS    | Revenue       |
| :--------- | :----- | :------------ |
| 2025-05-07 | 6.9    | 109.58 B$     |
| 2024-11-04 | 6.56   | 100.82 B$     |
| 2024-08-09 | 4.58   | 98.86 B$      |
| 2024-05-09 | -1.53  | 99.80 B$      |
| 2025-05-07 | -1.53  | 99.80 B$      |

**Analysis:** Revenue has been generally increasing, with the latest quarter reaching 109.58 B$. However, EPS has been inconsistent, with two recent quarters showing negative values (-1.53), which is concerning. The recent earning is 6.9.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue       | Profit Margin |
| :----------- | :------------ | :------------ |
| 2025-03-31   | $109.58B     | 21.70%        |
| 2024-12-31   | $100.81B     | 21.14%        |
| 2024-09-30   | $100.82B     | 22.84%        |
| 2024-06-30   | $98.86B      | 22.31%        |
| 2024-03-31   | $99.80B      | 23.05%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE     |
| :----------- | :---------- | :------ |
| 2025-03-31   | $95.04B    | 6.62%   |
| 2024-12-31   | $92.66B    | 5.98%   |
| 2024-09-30   | $94.53B    | 6.41%   |
| 2024-06-30   | $89.36B    | 4.72%   |
| 2024-03-31   | $86.69B    | -1.63%  |

**Analysis:**

*   **Revenue & Profitability:** Revenue shows a positive trajectory. Profit margins have been relatively stable, fluctuating between 21% and 23%, which indicates consistent profitability.
*   **Capital & Profitability:** Equity has generally increased, reflecting positive asset growth. However, ROE (Return on Equity) has shown some volatility, with the lowest point being -1.63% in Q1 2024, followed by a recovery. The recent ROE is 6.62%.

**7. Overall Analysis & Conclusion**

The analysis of UnitedHealth Group Inc (UNH) reveals a mixed picture. While the company demonstrates strong revenue growth and generally stable profit margins, its stock performance has significantly lagged behind the S&P 500. Key concerns include the substantial negative divergence, recent earnings volatility (negative EPS in some quarters), and a very negative expected return.

The technical indicators suggest the stock is oversold, which could lead to a short-term bounce. However, the overall trend is bearish, and investors should exercise caution. The recent news indicates increased scrutiny and volatility, which further complicates the outlook.

**Recommendation:** Based on this analysis, a cautious approach is warranted. While the oversold conditions might present a speculative short-term opportunity, the long-term outlook remains uncertain. Investors should closely monitor upcoming earnings reports, company announcements, and industry trends before making any investment decisions.
